Investor relations

Pulsenmore offers innovative home ultrasound technology that is transforming prenatal care. Our solutions meet the growing demand for remote healthcare services, particularly in prenatal care, telemedicine, and femtech. Pulsenmore aligns with the global trend towards digital health solutions and remote patient monitoring, and provides efficient alternatives to traditional hospital visits, benefiting both healthcare systems and patients.


The detailed numbers

  • Publicly traded in the Tel-Aviv Stock Exchange (TASE:PULS)
  • IPO: June 2021, $56 raised
  • Investment to-date including IPO:$90M
Strategic partners icon
Strategic partners
  • GE HealthCare: $21M investment & non exclusive distribution rights
  • Clalit Health Services, the biggest HMO In Israel: multi-million-dollar agreement
patents icon
  • Launched : Home Ultrasound solution for pregnant women (Pulsenmore ES)
  • Roadmap Products: Home Ultrasound for women undergoing IVF and for CHF patients 
team icon
  • Experienced management and 57% female majority in the board of directors
  • High proficiency in ultrasound, cloud architecture and automation
  • Over 70 patents filed, 15 granted
regulations icon
  • Europe (CE), U.K, Switzerland, Australia (TGA), Brazil (ANVISA), Israel (AMAR)
Doria Marley and baby at Pulsenmore office
Doria Marley and baby at Pulsenmore office

The big numbers


Investment raised including IPO


Accessible maternal care market


Pregnancies worldwide each year


Pulsenmore self-scans performed to date

Corporate updates

Public report of 2023

Click on the link to access the report

General meeting on July 7th, 2024

Click on the link below to see Pulsenmore announcement

Agreement with a distributor in Italy for the import and distribution of Pulsenmore ES

Official report link

Periodic and annual report for 2023

Click on the link below to access the report הודעה מלאה>>

Agreement Signed with the University of Michigan

Pulsenmore Americas LLC entered into an agreement for a clinical trial with the academic institution Regents of the University of Michigan led by Prof. Alex

Agreement Signed with Sheba Beyond

On February 29, 2024 Pulsenmore entered into an agreement with the Sheba Medical Center through the Sheba Beyond Research and Health Services Fund – the

Award winning technology